Evidence map›Paper›PMID 19035513›Full record

ArticleArthritis and rheumatism2008

Persistent arthritis in Borrelia burgdorferi-infected HLA-DR4-positive CD28-negative mice post-antibiotic treatment.

Bettina Panagiota Iliopoulou, Joseph Alroy, Brigitte T Huber

Open access · greenAbstract read
In one paragraph

Article in Arthritis and rheumatism, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 26 citations in OpenAlex.

  1. Frontiers in cellular and infection microbiology · 2025
    Article
  2. Lyme Arthritis: A 50-Year Journey.The Journal of infectious diseases · 2024
    Article
  3. Persistent Borrelia burgdorferiClinical microbiology reviews · 2022
    Review
  4. Review
  5. Lyme Disease Frontiers: ReconcilingPathogens (Basel, Switzerland) · 2019
    Review
  6. Relationship between immunity to Borrelia burgdorferi outer-surface protein A (OspA) and Lyme arthritis.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2011
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Bettina Panagiota IliopoulouTufts University School of Medicine, Boston, Massachusetts 02111, USA.
Joseph Alroy
Brigitte T Huber
Tufts University · US

Funding

CHRONIC LYME ARTHRITIS--IS THIS AUTOIMMUNITY?R01AR045386 · NIAMS · TUFTS UNIVERSITY BOSTON · PI HUBER, BRIGITTE T. · 1998 to 2005
$1.8M
NIAMS NIH HHS R01 AR045386NIAMS NIH HHS R01-AR-45386NIDDK NIH HHS DK-34924
6 · The paper itself

Abstract

objectiveThe immunologic events that lead to persistent joint inflammation in certain patients with Lyme arthritis post-antibiotic treatment have been elusive so far. The prevalence of this condition is highest in individuals with rheumatoid arthritis-associated HLA-DR alleles. This study was undertaken to generate a murine model with persistent arthritis post-antibiotic treatment.

methodsWe have previously shown that CD28(-/-) mice develop intermittent monarticular Lyme arthritis that is responsive to antibiotics. Since there seems to be a link in humans between persistent arthritic manifestations post-antibiotic treatment and the HLA-DR4 allele, we generated DR4+/+CD28(-/-)MHCII(-/-) mice, infected them with Borrelia burgdorferi, and subsequently treated them with antibiotics.

resultsThirty-eight percent of the B burgdorferi-infected DR4+/+CD28(-/-)MHCII(-/-) mice, but none of the B burgdorferi-infected CD28(-/-)MHCII(-/-) mice, remained arthritic post-antibiotic treatment. A significant fraction (36%) of these mice, but none of the mice in which arthritis resolved, had serum antibodies to outer surface protein A of B burgdorferi. After abrogation of active B burgdorferi infection, the inflammatory reaction in mice with persistent joint inflammation was restricted to the joints, since their draining lymph nodes were no longer enlarged. Increased CD20 and interferon-gamma messenger RNA expression in the inflamed joints of these mice suggested a possible role of B cells and inflammatory cytokines in the pathogenesis of persistent arthritis post-antibiotic treatment.

conclusionThe establishment of this murine model allows, for the first time, the elucidation of the immunologic events that lead to persistent Lyme arthritis post-antibiotic therapy in genetically susceptible individuals.

Indexed as

Borrelia burgdorferiAnimalsAnti-Bacterial AgentsAntibodies, BacterialAntigens, CD20Antigens, SurfaceArthritis, InfectiousBacterial Outer Membrane ProteinsBacterial VaccinesB-LymphocytesCD28 AntigensDisease Models, AnimalFemaleGenes, MHC Class IIHLA-DR4 AntigenHumansAnti-Bacterial AgentsAntibodies, BacterialAntigens, CD20Antigens, SurfaceBacterial Outer Membrane ProteinsBacterial VaccinesCD28 AntigensHLA-DR4 AntigenInterferon-gammaLipoproteinsOspA proteinRNA, Messenger

Identifiers

PMID19035513
PMCPMC2775539
OpenAlexW2158670422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.